A Case of Histiocytic Sarcoma Arising from Mycosis Fungoides.
Journal
Case reports in hematology
ISSN: 2090-6560
Titre abrégé: Case Rep Hematol
Pays: United States
ID NLM: 101576456
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
04
2019
revised:
15
08
2019
accepted:
11
09
2019
entrez:
6
11
2019
pubmed:
7
11
2019
medline:
7
11
2019
Statut:
epublish
Résumé
Histiocytic sarcoma (HS) is an uncommon malignant neoplasm arising from mature histiocytes and most commonly characterized by the immunophenotypic expression of CD68, CD163, or lysozyme. Although rare, HS arising as a second primary malignancy following hematolymphoid neoplasms has been reported. To our knowledge, this is the first reported case of HS occurring as a second primary malignancy in a patient with mycosis fungoides (MF), with the retained immunophenotype markers CD30 and CD4.
Identifiants
pubmed: 31687231
doi: 10.1155/2019/7834728
pmc: PMC6794960
doi:
Types de publication
Case Reports
Langues
eng
Pagination
7834728Informations de copyright
Copyright © 2019 Ethan A. Burns et al.
Déclaration de conflit d'intérêts
The authors declare they have no conflicts of interest.
Références
Nat Immunol. 2011 Mar;12(3):247-54
pubmed: 21278738
J Clin Exp Hematop. 2013;53(1):1-8
pubmed: 23801128
Clin Cancer Res. 2013 Jul 15;19(14):3755-63
pubmed: 23785046
Head Neck. 1999 Jul;21(4):346-54
pubmed: 10376755
Radiat Oncol J. 2018 Jun;36(2):85-94
pubmed: 29983028
Blood. 2003 Dec 1;102(12):4059-66
pubmed: 12829591
Intern Med. 2008;47(3):165-9
pubmed: 18239326
Blood. 2018 Jan 11;131(2):265-268
pubmed: 29183888
Nature. 2000 Mar 9;404(6774):193-7
pubmed: 10724173
J Invest Dermatol. 2017 Jul;137(7):1523-1532
pubmed: 28288848
Eur J Haematol. 2016 Jul;97(1):9-16
pubmed: 26990812
Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):
pubmed: 28289245
Cancer Biol Ther. 2011 Dec 15;12(12):1019-22
pubmed: 22236880
Haematologica. 2012 Oct;97(10):1553-61
pubmed: 22419579
Leukemia. 2016 Apr;30(4):955-8
pubmed: 26202925
Blood. 2008 Jun 15;111(12):5433-9
pubmed: 18272816
Br J Cancer. 2016 Mar 15;114(6):605-11
pubmed: 26908329
J Clin Invest. 2005 Apr;115(4):798-812
pubmed: 15841167
Blood. 2015 Apr 30;125(18):2798-805
pubmed: 25628470
Hum Pathol. 2013 Jun;44(6):1177-83
pubmed: 23356953
Sci Transl Med. 2016 Feb 24;8(327):327ra24
pubmed: 26912903
Front Oncol. 2018 Oct 17;8:449
pubmed: 30386739
Cancer. 2006 Jul 1;107(1):108-15
pubmed: 16708354
Nat Rev Cancer. 2009 Aug;9(8):596-604
pubmed: 19629073
J Dermatol. 2013 Aug;40(8):596-605
pubmed: 23682716
Cell. 2013 Feb 14;152(4):714-26
pubmed: 23415222